Spathakis, M.; Dovrolis, N.; Filidou, E.; Kandilogiannakis, L.; Tarapatzi, G.; Valatas, V.; Drygiannakis, I.; Paspaliaris, V.; Arvanitidis, K.; Manolopoulos, V.G.;
et al. Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and Fibrosis. Pharmaceuticals 2024, 17, 492.
https://doi.org/10.3390/ph17040492
AMA Style
Spathakis M, Dovrolis N, Filidou E, Kandilogiannakis L, Tarapatzi G, Valatas V, Drygiannakis I, Paspaliaris V, Arvanitidis K, Manolopoulos VG,
et al. Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and Fibrosis. Pharmaceuticals. 2024; 17(4):492.
https://doi.org/10.3390/ph17040492
Chicago/Turabian Style
Spathakis, Michail, Nikolas Dovrolis, Eirini Filidou, Leonidas Kandilogiannakis, Gesthimani Tarapatzi, Vassilis Valatas, Ioannis Drygiannakis, Vasilis Paspaliaris, Konstantinos Arvanitidis, Vangelis G. Manolopoulos,
and et al. 2024. "Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and Fibrosis" Pharmaceuticals 17, no. 4: 492.
https://doi.org/10.3390/ph17040492
APA Style
Spathakis, M., Dovrolis, N., Filidou, E., Kandilogiannakis, L., Tarapatzi, G., Valatas, V., Drygiannakis, I., Paspaliaris, V., Arvanitidis, K., Manolopoulos, V. G., Kolios, G., & Vradelis, S.
(2024). Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and Fibrosis. Pharmaceuticals, 17(4), 492.
https://doi.org/10.3390/ph17040492
